Dose Escalation

Dose Escalation is a clinical trial methodology involving the systematic increase of therapeutic agent dosage across successive patient cohorts to determine the optimal balance between efficacy and safety in the context of cell or gene therapy translation.

2.5K

Publications

177.3K

Citations

19.5K

Authors

4K

Institutions

Publications per year

2017–2026

835

Authors

19.5K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    85 publications · 12.9K citations

    43

    h-index

  2. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    63 publications · 7K citations

    36

    h-index

  3. MJ
    Mark J. Levis

    Johns Hopkins University, United States

    31 publications · 3.7K citations

    25

    h-index

  4. GG
    Guillermo Garcia‐Manero

    The University of Texas MD Anderson Cancer Center, United States

    39 publications · 3.8K citations

    25

    h-index

  5. FR
    Farhad Ravandi

    The University of Texas MD Anderson Cancer Center, United States

    44 publications · 6.1K citations

    25

    h-index

1–5 of 19.5K

Venues

  1. Journal of Clinical Oncology

    303 publications · 28.7K citations

    91

    h-index

  2. Blood

    258 publications · 23.1K citations

    65

    h-index

  3. Clinical Cancer Research

    63 publications · 5.6K citations

    45

    h-index

  4. 44

    h-index

  5. PubMed

    Repository · 113 publications · 7K citations

    39

    h-index

1–5